Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfap2a
|
ENSMUSG00000021359.9 | transcription factor AP-2, alpha |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_40729414_40730308 | Tfap2a | 458 | 0.669740 | 0.75 | 4.1e-12 | Click! |
chr13_40729030_40729381 | Tfap2a | 198 | 0.867751 | 0.73 | 5.7e-11 | Click! |
chr13_40732680_40733858 | Tfap2a | 509 | 0.646413 | 0.72 | 1.0e-10 | Click! |
chr13_40731940_40732438 | Tfap2a | 582 | 0.591769 | 0.68 | 2.5e-09 | Click! |
chr13_40731061_40731804 | Tfap2a | 175 | 0.901541 | 0.68 | 2.8e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_170674573_170675954 | 12.60 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr4_148286849_148288201 | 5.72 |
Disp3 |
dispatched RND transporter family member 3 |
440 |
0.81 |
chr14_39473185_39473855 | 5.37 |
Nrg3 |
neuregulin 3 |
432 |
0.91 |
chr7_139086002_139087206 | 5.22 |
Dpysl4 |
dihydropyrimidinase-like 4 |
576 |
0.74 |
chr6_3134749_3135336 | 5.09 |
Vmn1r261 |
vomeronasal 1 receptor 261 |
9512 |
0.15 |
chr4_3180418_3180743 | 4.65 |
Vmn1r3 |
vomeronasal 1 receptor 3 |
4778 |
0.19 |
chr4_142588283_142589081 | 4.62 |
Gm37624 |
predicted gene, 37624 |
202126 |
0.02 |
chr18_20622092_20622498 | 4.58 |
Gm16090 |
predicted gene 16090 |
42965 |
0.11 |
chr13_99513069_99513554 | 4.48 |
Map1b |
microtubule-associated protein 1B |
3207 |
0.2 |
chr14_28508967_28511864 | 4.33 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr7_12015381_12015902 | 4.32 |
Gm18854 |
predicted gene, 18854 |
9810 |
0.06 |
chr10_3863416_3864702 | 4.31 |
Gm16149 |
predicted gene 16149 |
5548 |
0.21 |
chrX_152643367_152644550 | 4.29 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr15_87544354_87545329 | 4.28 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr13_72629730_72632045 | 4.23 |
Irx2 |
Iroquois homeobox 2 |
1062 |
0.51 |
chr5_113490881_113491656 | 4.17 |
Wscd2 |
WSC domain containing 2 |
516 |
0.83 |
chr12_86989498_86990698 | 4.12 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
332 |
0.85 |
chr4_150651111_150652374 | 3.95 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr11_3370456_3371381 | 3.86 |
Limk2 |
LIM motif-containing protein kinase 2 |
417 |
0.76 |
chr17_93198991_93201483 | 3.85 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr5_111418246_111419747 | 3.82 |
Mn1 |
meningioma 1 |
1554 |
0.34 |
chr17_68836792_68837954 | 3.81 |
Gm38593 |
predicted gene, 38593 |
147 |
0.62 |
chr8_12947702_12949640 | 3.81 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr5_130449887_130450187 | 3.76 |
Caln1 |
calneuron 1 |
1236 |
0.55 |
chr3_87949543_87950464 | 3.74 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr4_3178062_3178308 | 3.71 |
Vmn1r2 |
vomeronasal 1 receptor 2 |
6102 |
0.18 |
chr4_3177527_3177893 | 3.70 |
Vmn1r2 |
vomeronasal 1 receptor 2 |
5627 |
0.18 |
chr18_3113271_3113666 | 3.70 |
Gm50073 |
predicted gene, 50073 |
8072 |
0.15 |
chr10_34299043_34301066 | 3.69 |
Tspyl4 |
TSPY-like 4 |
798 |
0.4 |
chr4_41639077_41640217 | 3.65 |
Gm12406 |
predicted gene 12406 |
269 |
0.71 |
chr5_38153230_38154533 | 3.61 |
Nsg1 |
neuron specific gene family member 1 |
5150 |
0.17 |
chr2_172040251_172043672 | 3.58 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr6_6878154_6880927 | 3.54 |
Dlx5 |
distal-less homeobox 5 |
2528 |
0.19 |
chr1_194623571_194625393 | 3.52 |
Plxna2 |
plexin A2 |
4657 |
0.21 |
chr7_43489310_43490670 | 3.46 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chrX_43427994_43428603 | 3.45 |
Tenm1 |
teneurin transmembrane protein 1 |
705 |
0.72 |
chr3_154329308_154331090 | 3.45 |
Lhx8 |
LIM homeobox protein 8 |
140 |
0.88 |
chr6_54564534_54565307 | 3.39 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr4_103619552_103620735 | 3.39 |
Dab1 |
disabled 1 |
478 |
0.8 |
chr7_44441951_44442938 | 3.38 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr14_25610327_25611867 | 3.32 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
3259 |
0.25 |
chr4_137664773_137665940 | 3.30 |
Rap1gap |
Rap1 GTPase-activating protein |
602 |
0.71 |
chr6_90809120_90810568 | 3.23 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
279 |
0.89 |
chr16_60605121_60606481 | 3.22 |
Gm9017 |
predicted gene 9017 |
46 |
0.78 |
chr9_41378412_41379411 | 3.21 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr6_55451730_55453138 | 3.20 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
257 |
0.93 |
chrX_104199711_104200337 | 3.18 |
Nexmif |
neurite extension and migration factor |
1093 |
0.59 |
chr13_51566607_51568077 | 3.18 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
258 |
0.94 |
chr5_103209022_103210413 | 3.17 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr11_93097392_93097759 | 3.16 |
Car10 |
carbonic anhydrase 10 |
453 |
0.9 |
chr7_113765738_113767100 | 3.16 |
Spon1 |
spondin 1, (f-spondin) extracellular matrix protein |
245 |
0.94 |
chr2_181313043_181314281 | 3.15 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr7_79504311_79505700 | 3.15 |
Mir9-3 |
microRNA 9-3 |
259 |
0.82 |
chr2_109693096_109694906 | 3.14 |
Bdnf |
brain derived neurotrophic factor |
408 |
0.85 |
chr17_93201490_93204144 | 3.14 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr11_76466993_76468433 | 3.10 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr7_12016565_12017148 | 3.09 |
Gm18854 |
predicted gene, 18854 |
8595 |
0.06 |
chr4_13744037_13744679 | 3.09 |
Runx1t1 |
RUNX1 translocation partner 1 |
922 |
0.71 |
chr3_8509825_8511666 | 3.07 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr4_125490136_125491914 | 3.06 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr6_145075061_145076261 | 3.05 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
523 |
0.72 |
chr1_92849002_92850443 | 3.04 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr2_118779656_118780774 | 3.02 |
Disp2 |
dispatched RND tramsporter family member 2 |
456 |
0.71 |
chr8_92359084_92360805 | 3.01 |
Irx5 |
Iroquois homeobox 5 |
2195 |
0.28 |
chr18_79105943_79106581 | 3.00 |
Setbp1 |
SET binding protein 1 |
3129 |
0.37 |
chr7_84528418_84529713 | 3.00 |
Gm2115 |
predicted gene 2115 |
73 |
0.97 |
chr5_113462155_113462579 | 2.97 |
Wscd2 |
WSC domain containing 2 |
27966 |
0.18 |
chrX_134405492_134405850 | 2.95 |
Drp2 |
dystrophin related protein 2 |
869 |
0.59 |
chr7_141428600_141429722 | 2.95 |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
190 |
0.82 |
chr8_94994139_94995207 | 2.95 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
77 |
0.95 |
chr1_75421841_75423544 | 2.94 |
Speg |
SPEG complex locus |
818 |
0.43 |
chr12_80759551_80760722 | 2.93 |
Ccdc177 |
coiled-coil domain containing 177 |
551 |
0.62 |
chr11_103776117_103777283 | 2.88 |
Wnt3 |
wingless-type MMTV integration site family, member 3 |
2550 |
0.24 |
chr4_64045841_64047503 | 2.87 |
Tnc |
tenascin C |
343 |
0.9 |
chr8_123413418_123414506 | 2.85 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr5_112575572_112575844 | 2.84 |
Sez6l |
seizure related 6 homolog like |
1160 |
0.42 |
chr14_122475443_122476757 | 2.84 |
Zic2 |
zinc finger protein of the cerebellum 2 |
665 |
0.44 |
chr2_178175169_178175781 | 2.84 |
Phactr3 |
phosphatase and actin regulator 3 |
126 |
0.98 |
chr6_112945034_112945954 | 2.83 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
1260 |
0.31 |
chr11_55607331_55608633 | 2.83 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr15_25414267_25414862 | 2.82 |
Gm5468 |
predicted gene 5468 |
372 |
0.48 |
chr5_111421306_111422790 | 2.79 |
Gm43119 |
predicted gene 43119 |
1541 |
0.35 |
chr14_55826099_55826996 | 2.79 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
491 |
0.63 |
chr15_11036089_11037859 | 2.78 |
Rxfp3 |
relaxin family peptide receptor 3 |
1017 |
0.52 |
chr1_79857842_79858676 | 2.78 |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
376 |
0.88 |
chr14_108912235_108913525 | 2.78 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
1278 |
0.64 |
chr3_108410436_108412210 | 2.78 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr15_71727651_71728452 | 2.77 |
Fam135b |
family with sequence similarity 135, member B |
213 |
0.95 |
chr13_83715222_83716973 | 2.77 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr2_136058799_136059736 | 2.76 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
164 |
0.96 |
chr18_60925301_60926809 | 2.76 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr6_77978407_77979215 | 2.74 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
739 |
0.71 |
chr5_136881600_136883223 | 2.74 |
Col26a1 |
collagen, type XXVI, alpha 1 |
332 |
0.82 |
chrX_86191680_86192868 | 2.73 |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
510 |
0.82 |
chr19_5463295_5464559 | 2.73 |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
283 |
0.68 |
chr14_122477033_122477655 | 2.72 |
Zic2 |
zinc finger protein of the cerebellum 2 |
756 |
0.48 |
chr13_55484574_55485692 | 2.72 |
Dbn1 |
drebrin 1 |
1164 |
0.26 |
chr11_103773284_103774731 | 2.72 |
Wnt3 |
wingless-type MMTV integration site family, member 3 |
143 |
0.95 |
chr15_92050857_92052193 | 2.71 |
Cntn1 |
contactin 1 |
360 |
0.9 |
chr14_70554181_70555469 | 2.71 |
Hr |
lysine demethylase and nuclear receptor corepressor |
769 |
0.47 |
chr2_72055458_72056697 | 2.71 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
1092 |
0.57 |
chr3_99255907_99257438 | 2.71 |
Tbx15 |
T-box 15 |
2912 |
0.22 |
chr5_120433178_120434996 | 2.70 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr5_111420704_111420913 | 2.68 |
Gm43119 |
predicted gene 43119 |
2781 |
0.22 |
chr15_34837199_34838365 | 2.68 |
Kcns2 |
K+ voltage-gated channel, subfamily S, 2 |
267 |
0.93 |
chr16_5306842_5307937 | 2.68 |
Gm41414 |
predicted gene, 41414 |
588 |
0.68 |
chr11_80481116_80481835 | 2.67 |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
4419 |
0.21 |
chr10_80300884_80302968 | 2.67 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr11_97574297_97574586 | 2.67 |
Srcin1 |
SRC kinase signaling inhibitor 1 |
388 |
0.79 |
chr7_78575992_78576673 | 2.66 |
Gm39038 |
predicted gene, 39038 |
1100 |
0.39 |
chr3_145292300_145293786 | 2.66 |
Col24a1 |
collagen, type XXIV, alpha 1 |
516 |
0.85 |
chr3_102011198_102013204 | 2.64 |
Nhlh2 |
nescient helix loop helix 2 |
2046 |
0.32 |
chr5_13125231_13126281 | 2.63 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
163 |
0.95 |
chr15_78947966_78948802 | 2.63 |
Triobp |
TRIO and F-actin binding protein |
139 |
0.9 |
chr7_12017388_12017543 | 2.61 |
Gm18854 |
predicted gene, 18854 |
7986 |
0.07 |
chr7_51629095_51630495 | 2.60 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
315 |
0.88 |
chr18_82405647_82407688 | 2.59 |
Galr1 |
galanin receptor 1 |
110 |
0.96 |
chr2_49619321_49620607 | 2.59 |
Kif5c |
kinesin family member 5C |
666 |
0.78 |
chr3_80800286_80803016 | 2.59 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr14_84446983_84448692 | 2.59 |
Pcdh17 |
protocadherin 17 |
670 |
0.76 |
chr15_78717784_78718525 | 2.58 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
41 |
0.97 |
chr4_143349521_143350697 | 2.58 |
Lrrc38 |
leucine rich repeat containing 38 |
352 |
0.83 |
chr19_47493153_47493953 | 2.58 |
Stn1 |
STN1, CST complex subunit |
15220 |
0.15 |
chr14_122478089_122479067 | 2.58 |
Zic2 |
zinc finger protein of the cerebellum 2 |
478 |
0.68 |
chr11_116919008_116919761 | 2.57 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
521 |
0.75 |
chrX_73879886_73880799 | 2.56 |
L1cam |
L1 cell adhesion molecule |
453 |
0.7 |
chr6_77244137_77244322 | 2.56 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
1307 |
0.55 |
chr1_18057820_18058958 | 2.55 |
Gm45784 |
predicted gene 45784 |
120 |
0.8 |
chr10_21883302_21884037 | 2.55 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
1300 |
0.42 |
chr7_78882466_78883900 | 2.55 |
Mir7-2 |
microRNA 7-2 |
5094 |
0.13 |
chr18_77563866_77564228 | 2.54 |
Rnf165 |
ring finger protein 165 |
562 |
0.8 |
chr1_159524626_159524870 | 2.53 |
Tnr |
tenascin R |
907 |
0.65 |
chrX_100768770_100769163 | 2.51 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
971 |
0.5 |
chr1_136231257_136232167 | 2.51 |
Inava |
innate immunity activator |
1402 |
0.26 |
chr9_69758963_69761490 | 2.51 |
Foxb1 |
forkhead box B1 |
714 |
0.5 |
chr3_88831100_88832914 | 2.50 |
1500004A13Rik |
RIKEN cDNA 1500004A13 gene |
361 |
0.77 |
chr9_114057100_114058099 | 2.50 |
Susd5 |
sushi domain containing 5 |
459 |
0.81 |
chr14_65952886_65954310 | 2.50 |
Scara3 |
scavenger receptor class A, member 3 |
337 |
0.86 |
chr3_88771097_88772528 | 2.49 |
Syt11 |
synaptotagmin XI |
787 |
0.45 |
chr8_11187747_11188818 | 2.48 |
Gm15418 |
predicted gene 15418 |
527 |
0.75 |
chr10_80298461_80300404 | 2.47 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr3_89215230_89216068 | 2.47 |
Thbs3 |
thrombospondin 3 |
416 |
0.53 |
chr18_36067825_36068916 | 2.47 |
Nrg2 |
neuregulin 2 |
255 |
0.92 |
chr5_36868663_36870303 | 2.46 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr5_37245879_37246957 | 2.46 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr5_47984794_47986445 | 2.46 |
Slit2 |
slit guidance ligand 2 |
625 |
0.68 |
chr1_17727029_17728148 | 2.44 |
Gm16070 |
predicted gene 16070 |
58 |
0.89 |
chr4_148130089_148131325 | 2.44 |
Draxin |
dorsal inhibitory axon guidance protein |
9 |
0.72 |
chrX_72655248_72656218 | 2.44 |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
453 |
0.82 |
chr1_19213854_19215338 | 2.44 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr13_75089525_75090889 | 2.44 |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
291 |
0.94 |
chr4_111416614_111417196 | 2.43 |
Bend5 |
BEN domain containing 5 |
1698 |
0.42 |
chr4_3175732_3175907 | 2.42 |
Vmn1r2 |
vomeronasal 1 receptor 2 |
3736 |
0.2 |
chr17_85679503_85681370 | 2.42 |
Six2 |
sine oculis-related homeobox 2 |
7818 |
0.18 |
chr2_38351207_38353752 | 2.42 |
Lhx2 |
LIM homeobox protein 2 |
53 |
0.96 |
chr16_44553746_44555096 | 2.41 |
Mir3081 |
microRNA 3081 |
3708 |
0.24 |
chr4_3165069_3165416 | 2.40 |
Vmn1r2 |
vomeronasal 1 receptor 2 |
2078 |
0.28 |
chr5_111580966_111582197 | 2.40 |
C130026L21Rik |
RIKEN cDNA C130026L21 gene |
13 |
0.98 |
chr17_42315796_42317065 | 2.39 |
Ptchd4 |
patched domain containing 4 |
170 |
0.98 |
chrX_143930842_143933141 | 2.39 |
Dcx |
doublecortin |
1059 |
0.64 |
chr5_120711312_120711715 | 2.39 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
414 |
0.73 |
chr14_4649261_4650460 | 2.39 |
Gm3239 |
predicted gene 3239 |
14332 |
0.11 |
chr14_122472255_122473599 | 2.38 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
652 |
0.55 |
chr2_152080491_152081480 | 2.37 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr3_88527409_88528188 | 2.37 |
Gm37584 |
predicted gene, 37584 |
443 |
0.62 |
chr4_134470669_134471383 | 2.36 |
Stmn1 |
stathmin 1 |
1284 |
0.28 |
chr2_51144318_51145477 | 2.35 |
Rnd3 |
Rho family GTPase 3 |
4197 |
0.29 |
chr2_25877424_25878675 | 2.35 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr19_56873965_56875080 | 2.34 |
Vwa2 |
von Willebrand factor A domain containing 2 |
273 |
0.92 |
chr2_52860105_52860808 | 2.33 |
Fmnl2 |
formin-like 2 |
2588 |
0.39 |
chr6_77243534_77244121 | 2.33 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
905 |
0.69 |
chr18_35213919_35214231 | 2.33 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
855 |
0.42 |
chr3_87947557_87949450 | 2.33 |
Crabp2 |
cellular retinoic acid binding protein II |
163 |
0.9 |
chr12_67219520_67219941 | 2.33 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1312 |
0.58 |
chr11_93098807_93100169 | 2.33 |
Car10 |
carbonic anhydrase 10 |
198 |
0.97 |
chr9_41584760_41585051 | 2.33 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2864 |
0.14 |
chr9_61376232_61377980 | 2.32 |
Tle3 |
transducin-like enhancer of split 3 |
1577 |
0.38 |
chr8_87471412_87471563 | 2.32 |
Cbln1 |
cerebellin 1 precursor protein |
419 |
0.7 |
chr14_118231082_118232196 | 2.30 |
Gm4675 |
predicted gene 4675 |
4593 |
0.14 |
chr16_28752596_28753856 | 2.30 |
Fgf12 |
fibroblast growth factor 12 |
158 |
0.97 |
chr1_66386552_66386869 | 2.30 |
Map2 |
microtubule-associated protein 2 |
235 |
0.94 |
chr3_118434232_118434838 | 2.30 |
Gm24155 |
predicted gene, 24155 |
186 |
0.48 |
chr2_170731776_170732705 | 2.29 |
Dok5 |
docking protein 5 |
433 |
0.88 |
chr1_36254586_36255499 | 2.29 |
Uggt1 |
UDP-glucose glycoprotein glucosyltransferase 1 |
10322 |
0.15 |
chr6_124998125_124999247 | 2.28 |
Pianp |
PILR alpha associated neural protein |
47 |
0.94 |
chr15_74563319_74564610 | 2.28 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
63 |
0.61 |
chr7_34593866_34595021 | 2.28 |
Gm44837 |
predicted gene 44837 |
43269 |
0.1 |
chr10_58812359_58813662 | 2.28 |
Gm9987 |
predicted gene 9987 |
132 |
0.76 |
chr4_3180151_3180369 | 2.27 |
Vmn1r3 |
vomeronasal 1 receptor 3 |
5098 |
0.18 |
chr9_52678302_52679671 | 2.26 |
AI593442 |
expressed sequence AI593442 |
443 |
0.69 |
chrX_58030987_58032527 | 2.26 |
Zic3 |
zinc finger protein of the cerebellum 3 |
747 |
0.74 |
chr3_117359414_117360458 | 2.25 |
Plppr4 |
phospholipid phosphatase related 4 |
312 |
0.92 |
chr6_105678414_105679444 | 2.25 |
Cntn4 |
contactin 4 |
1154 |
0.43 |
chr3_96597407_96598696 | 2.25 |
Ankrd34a |
ankyrin repeat domain 34A |
1415 |
0.17 |
chr8_125994981_125996355 | 2.24 |
Kcnk1 |
potassium channel, subfamily K, member 1 |
232 |
0.94 |
chr1_63445846_63446823 | 2.24 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
123 |
0.97 |
chr7_51623529_51624502 | 2.23 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
1133 |
0.51 |
chr8_50916657_50916808 | 2.23 |
C130073E24Rik |
RIKEN cDNA C130073E24 gene |
265 |
0.96 |
chr18_89768830_89769936 | 2.23 |
Dok6 |
docking protein 6 |
145 |
0.97 |
chr10_80383278_80383957 | 2.23 |
Gm22721 |
predicted gene, 22721 |
1315 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
2.1 | 6.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
2.0 | 5.9 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
2.0 | 5.9 | GO:0021586 | pons maturation(GO:0021586) |
1.9 | 5.7 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.8 | 3.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.8 | 5.3 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.7 | 12.1 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.6 | 4.8 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.5 | 4.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.5 | 5.9 | GO:0060596 | mammary placode formation(GO:0060596) |
1.4 | 4.2 | GO:0060174 | limb bud formation(GO:0060174) |
1.4 | 2.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.4 | 6.8 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.3 | 4.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.3 | 5.4 | GO:0060594 | mammary gland specification(GO:0060594) |
1.3 | 2.7 | GO:0070384 | Harderian gland development(GO:0070384) |
1.3 | 5.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.3 | 2.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
1.3 | 3.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.3 | 9.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.3 | 3.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.3 | 2.5 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
1.2 | 7.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.2 | 4.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.2 | 4.8 | GO:0007412 | axon target recognition(GO:0007412) |
1.2 | 3.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 11.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.2 | 4.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.2 | 3.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.1 | 3.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 3.3 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.1 | 3.3 | GO:0060166 | olfactory pit development(GO:0060166) |
1.1 | 3.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 3.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 3.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.1 | 3.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.1 | 1.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
1.0 | 7.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 8.3 | GO:0071625 | vocalization behavior(GO:0071625) |
1.0 | 3.1 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
1.0 | 3.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.0 | 1.0 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
1.0 | 5.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.0 | 5.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 4.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 3.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.0 | 1.0 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
1.0 | 2.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.0 | 2.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.9 | 1.9 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.9 | 2.8 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.9 | 22.0 | GO:0001964 | startle response(GO:0001964) |
0.9 | 3.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 0.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.9 | 3.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.9 | 4.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.9 | 2.7 | GO:0097503 | sialylation(GO:0097503) |
0.9 | 2.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 4.4 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.9 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.9 | 1.7 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.9 | 12.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.9 | 6.0 | GO:0072044 | collecting duct development(GO:0072044) |
0.8 | 2.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 4.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 2.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.8 | 4.8 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 1.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 3.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.8 | 0.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.8 | 6.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 3.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.8 | 2.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.8 | 0.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.8 | 1.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 2.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.7 | 3.7 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.7 | 1.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 1.5 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.7 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 5.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.7 | 5.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.7 | 1.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.7 | 2.1 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.7 | 0.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.7 | 2.1 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 9.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 1.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.7 | 0.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.7 | 2.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.7 | 2.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 1.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 7.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.7 | 5.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 0.7 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 2.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.7 | 2.0 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.7 | 35.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 3.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 1.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 1.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 1.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.6 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 2.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 2.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 1.3 | GO:0046959 | habituation(GO:0046959) |
0.6 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 1.3 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.6 | 3.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.6 | 1.9 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 3.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.6 | 4.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.6 | 7.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.6 | 0.6 | GO:1904238 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.6 | 1.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 1.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.6 | 1.8 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.6 | 3.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.6 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 3.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.6 | 0.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 1.8 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.6 | 0.6 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.6 | 1.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.6 | 1.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.6 | 2.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 1.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.6 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.6 | 5.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.6 | 0.6 | GO:0046958 | nonassociative learning(GO:0046958) |
0.6 | 1.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.6 | 2.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 1.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.6 | 8.6 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.6 | 5.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.6 | 6.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 0.6 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.6 | 1.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 0.6 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.6 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 1.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 2.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 3.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 2.7 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 2.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.5 | 2.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.5 | 1.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.5 | 1.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 2.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 0.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.5 | 1.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 1.6 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.5 | 1.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.5 | 1.6 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 3.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.5 | 1.6 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.5 | 1.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 6.3 | GO:0060384 | innervation(GO:0060384) |
0.5 | 4.2 | GO:0045176 | apical protein localization(GO:0045176) |
0.5 | 2.6 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.5 | 1.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 2.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.5 | 1.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.5 | 1.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.5 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 4.0 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) |
0.5 | 2.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 1.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 2.0 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 2.4 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.5 | 8.7 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.5 | 1.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.5 | 1.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.5 | 1.4 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.5 | 1.4 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 3.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 2.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.5 | 0.5 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.5 | 0.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 4.7 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 0.9 | GO:0008306 | associative learning(GO:0008306) |
0.5 | 0.9 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.5 | 0.9 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 8.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.5 | 0.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 5.9 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.5 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.4 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 0.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 2.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 4.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.4 | 1.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.4 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 3.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.4 | 0.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 0.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 0.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 2.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.4 | 0.8 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.4 | 1.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 0.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 0.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.4 | 30.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 0.4 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.4 | 0.8 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.4 | 2.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.4 | 1.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 1.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.4 | 0.4 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 0.8 | GO:0008355 | olfactory learning(GO:0008355) |
0.4 | 0.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 1.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 5.9 | GO:0003416 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.4 | 1.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 3.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 0.8 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 3.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.4 | 4.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.4 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.4 | 2.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.4 | 0.8 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.4 | 1.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.4 | 0.7 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 1.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 0.7 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 1.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.4 | 1.1 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.4 | 3.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.4 | 1.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.4 | 1.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 1.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 0.7 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.4 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 1.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 7.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.4 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 1.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.3 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 11.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.3 | 1.0 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.3 | 1.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 1.0 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.4 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 3.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.3 | 0.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 5.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 0.7 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 1.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.0 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.6 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.3 | 2.3 | GO:0008038 | neuron recognition(GO:0008038) |
0.3 | 1.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 1.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 1.0 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.3 | 2.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.3 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 2.2 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 2.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.3 | 3.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.3 | 0.9 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 0.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 9.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 7.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 0.9 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 0.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.6 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 2.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.3 | 1.5 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 2.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.3 | 1.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 3.8 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 0.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.3 | 0.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.3 | 1.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 2.3 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.3 | 0.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 1.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.3 | 0.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.3 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 1.9 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.3 | GO:0035106 | operant conditioning(GO:0035106) |
0.3 | 0.3 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.3 | 1.9 | GO:0014075 | response to amine(GO:0014075) |
0.3 | 1.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.3 | 0.8 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 1.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.1 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 4.5 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.3 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 1.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 5.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 0.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 1.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.5 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.5 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.3 | 0.8 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 1.0 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.3 | 3.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 0.3 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.3 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 2.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.5 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 0.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.2 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
0.2 | 0.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 1.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.2 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 1.2 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.7 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.2 | 0.2 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.2 | 0.5 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 1.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 4.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.5 | GO:0010536 | positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 13.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.2 | 2.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.2 | 1.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.2 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 0.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 1.3 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 3.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.2 | 0.4 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 16.2 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 1.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.6 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 1.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.2 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.2 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 0.8 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 1.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 0.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 1.6 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.2 | 1.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 2.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 1.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 2.6 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.6 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.2 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.2 | 0.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.8 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 1.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 2.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 2.8 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 1.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.2 | 0.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.2 | 0.2 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.2 | 0.9 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 0.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.4 | GO:0032098 | regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
0.2 | 0.2 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.2 | 1.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 0.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.3 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.9 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.2 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
0.2 | 0.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.2 | 2.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.3 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.8 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 0.2 | GO:0060164 | midbrain-hindbrain boundary morphogenesis(GO:0021555) oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.3 | GO:0052151 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.2 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 1.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.5 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.2 | GO:0033483 | gas homeostasis(GO:0033483) |
0.2 | 4.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 1.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.3 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 0.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 1.2 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.2 | 4.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 2.1 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 1.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 6.3 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.4 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 1.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.6 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.3 | GO:2000846 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.1 | 2.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.8 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.8 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 7.6 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 1.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.5 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.3 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 2.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.4 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.5 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.1 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 1.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.4 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.2 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.7 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.3 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.4 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 2.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.5 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.5 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 2.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.2 | GO:1903010 | regulation of bone development(GO:1903010) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.1 | 0.2 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 2.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.5 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.1 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.2 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 1.0 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.8 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 1.5 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.2 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 0.6 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.1 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 1.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.1 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.1 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.8 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.1 | 0.2 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.4 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0014831 | intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.0 | 0.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.0 | 1.9 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.0 | 0.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.6 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.0 | 0.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.2 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 2.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.0 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.0 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.1 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0070350 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.0 | GO:0048668 | collateral sprouting(GO:0048668) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.0 | 0.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.5 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.3 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.0 | 0.1 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.1 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.2 | 3.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.1 | 3.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.1 | 5.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.9 | 4.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 2.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 10.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.9 | 25.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.8 | 10.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 7.4 | GO:0016342 | catenin complex(GO:0016342) |
0.8 | 3.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 4.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 3.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 2.2 | GO:0044393 | microspike(GO:0044393) |
0.7 | 2.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 2.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 3.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.7 | 5.2 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.6 | 5.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 9.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 9.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 3.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.6 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 23.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.6 | 1.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
0.5 | 4.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 2.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.5 | 3.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.5 | 26.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 7.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.4 | 6.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 10.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 1.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 4.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 3.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 9.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 3.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 0.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 2.8 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 58.0 | GO:0060076 | excitatory synapse(GO:0060076) |
0.4 | 3.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 0.4 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 1.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 1.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.3 | 3.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 1.2 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 3.6 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 1.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 19.8 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 1.4 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 2.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 5.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.0 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 3.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 21.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 4.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 2.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.8 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 2.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 2.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 2.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.2 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.2 | 12.2 | GO:0045202 | synapse(GO:0045202) |
0.2 | 1.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 2.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 56.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 13.5 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 5.5 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 1.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 4.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.2 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 17.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 3.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 1.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.4 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 6.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 3.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 1.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 1.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 2.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 1.1 | GO:0043034 | costamere(GO:0043034) |
0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 3.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.7 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 8.7 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 2.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 4.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.4 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 2.7 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.0 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.4 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 18.0 | GO:0097458 | neuron part(GO:0097458) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.7 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.0 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.3 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.8 | 1.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.7 | 5.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.6 | 7.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 7.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 3.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.2 | 7.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.2 | 3.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.2 | 3.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 3.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.1 | 5.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 3.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 5.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.0 | 3.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 11.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.9 | 1.8 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.9 | 3.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.9 | 4.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 4.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 2.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.8 | 8.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.8 | 3.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 3.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.8 | 2.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.8 | 2.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.8 | 3.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 2.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.8 | 3.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 2.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.7 | 3.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 6.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 2.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 5.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.7 | 7.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 9.3 | GO:0016594 | glycine binding(GO:0016594) |
0.7 | 2.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 4.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.7 | 2.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.7 | 4.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.7 | 0.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.7 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.6 | 6.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 12.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 0.6 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 1.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.6 | 3.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 3.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 1.2 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 8.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.6 | 2.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 3.0 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.6 | 5.4 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 0.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 1.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 6.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 2.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.6 | 2.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.5 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 2.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.5 | 1.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.5 | 3.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.5 | 5.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 16.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.5 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 6.8 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 7.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 9.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.5 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 5.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 3.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 2.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 3.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.5 | 2.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 4.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 4.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 1.4 | GO:0034806 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.5 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 6.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.5 | 2.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.5 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 9.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 0.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.4 | 0.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.4 | 1.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.4 | 1.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 1.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 1.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.4 | 2.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 12.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 11.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.4 | 2.0 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 8.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 2.3 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.4 | 1.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 2.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 11.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 4.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 1.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.4 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.4 | 1.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.4 | 1.4 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.4 | 1.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 8.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.4 | 3.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 14.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 6.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 6.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 2.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 5.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 0.3 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.3 | 4.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 7.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 1.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 0.6 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.9 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 4.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 1.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 12.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 6.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 13.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 1.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 4.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 1.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 1.4 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 2.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 3.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 2.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 4.5 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 0.8 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 2.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 2.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 0.8 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 0.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 1.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 5.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 3.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 2.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 3.7 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 1.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 4.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 2.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 2.8 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 2.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.2 | 2.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 6.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 4.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 3.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 19.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 2.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.0 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 0.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.2 | 0.6 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 3.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 2.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.7 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 1.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.7 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.2 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 2.1 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 1.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.8 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 3.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.9 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.1 | 1.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 1.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 2.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.5 | GO:0070636 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 4.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 3.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 3.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 4.5 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 2.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 1.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 2.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 1.0 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 2.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 2.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.1 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 1.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 0.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 2.4 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 33.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.6 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.6 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 1.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.3 | GO:0052758 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 2.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0043759 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.4 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.0 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 2.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0034857 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.3 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.0 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.0 | 1.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 1.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.0 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 18.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.5 | 12.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 5.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 10.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
0.3 | 12.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 4.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 48.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 4.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 9.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 4.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 6.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 6.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 11.0 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.3 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 2.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 2.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 3.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 17.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 30.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 5.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 17.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 19.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.2 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 13.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.9 | 0.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.8 | 0.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.7 | 7.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 6.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.6 | 2.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 6.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 8.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 1.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 9.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.6 | 3.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 6.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 4.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 1.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.5 | 12.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 1.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 17.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 20.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.5 | 16.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 3.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 9.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 32.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 0.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 1.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.4 | 9.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 1.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.4 | 5.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 8.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.4 | 6.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 4.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 2.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 1.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.3 | 2.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 2.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 3.8 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 4.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 3.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 2.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 2.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 9.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 0.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 0.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 1.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 0.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 2.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 2.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 2.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 1.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 3.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 18.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 3.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 1.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.1 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 2.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.8 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 2.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |